Terra Nova Asset Management LLC acquired a new position in Zeltiq Aesthetics Inc. (NASDAQ:ZLTQ) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 20,265 shares of the company’s stock, valued at approximately $554,000. Terra Nova Asset Management LLC owned about 0.05% of Zeltiq Aesthetics as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in the company. BlackRock Fund Advisors raised its position in Zeltiq Aesthetics by 134.5% in the first quarter. BlackRock Fund Advisors now owns 2,098,036 shares of the company’s stock valued at $56,983,000 after buying an additional 1,203,254 shares in the last quarter. Deerfield Management Co. acquired a new position in Zeltiq Aesthetics during the first quarter valued at $29,996,000. Samlyn Capital LLC acquired a new position in Zeltiq Aesthetics during the first quarter valued at $29,100,000. RS Investment Management Co. LLC raised its position in Zeltiq Aesthetics by 35.3% in the second quarter. RS Investment Management Co. LLC now owns 1,056,821 shares of the company’s stock valued at $28,883,000 after buying an additional 275,499 shares in the last quarter. Finally, Granahan Investment Management Inc. MA raised its position in Zeltiq Aesthetics by 18.2% in the first quarter. Granahan Investment Management Inc. MA now owns 986,133 shares of the company’s stock valued at $26,783,000 after buying an additional 151,750 shares in the last quarter.

Zeltiq Aesthetics Inc. (NASDAQ:ZLTQ) traded up 0.92% during mid-day trading on Wednesday, reaching $39.33. The company had a trading volume of 948,159 shares. The company has a market capitalization of $1.56 billion, a P/E ratio of 59.14 and a beta of 0.80. Zeltiq Aesthetics Inc. has a one year low of $18.41 and a one year high of $40.98. The stock has a 50 day moving average price of $37.67 and a 200 day moving average price of $30.58.

Zeltiq Aesthetics (NASDAQ:ZLTQ) last issued its quarterly earnings results on Monday, August 8th. The company reported ($0.12) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.05) by $0.07. Zeltiq Aesthetics had a negative return on equity of 9.90% and a net margin of 9.54%. The business had revenue of $89.50 million for the quarter, compared to analyst estimates of $79.68 million. During the same quarter in the previous year, the business posted $0.03 earnings per share. The business’s revenue was up 38.9% on a year-over-year basis. On average, equities analysts expect that Zeltiq Aesthetics Inc. will post ($0.13) earnings per share for the current fiscal year.

Several research analysts have weighed in on ZLTQ shares. TheStreet lowered Zeltiq Aesthetics from a “buy” rating to a “hold” rating in a report on Friday, June 10th. Brean Capital reiterated a “buy” rating and set a $35.00 target price on shares of Zeltiq Aesthetics in a report on Tuesday, June 21st. Leerink Swann reiterated a “buy” rating on shares of Zeltiq Aesthetics in a report on Thursday, June 30th. Zacks Investment Research lowered Zeltiq Aesthetics from a “hold” rating to a “sell” rating in a report on Thursday, July 14th. Finally, Maxim Group lifted their target price on Zeltiq Aesthetics from $40.00 to $48.00 and gave the stock a “buy” rating in a report on Tuesday, August 9th. Three investment analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $39.89.

In other Zeltiq Aesthetics news, Director Andrew N. Schiff sold 500,000 shares of the stock in a transaction dated Thursday, August 11th. The stock was sold at an average price of $36.39, for a total transaction of $18,195,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Bradley Hauser sold 3,000 shares of the stock in a transaction dated Monday, July 11th. The stock was sold at an average price of $30.02, for a total value of $90,060.00. Following the sale, the vice president now owns 47,184 shares of the company’s stock, valued at $1,416,463.68. The disclosure for this sale can be found here. Company insiders own 15.60% of the company’s stock.

About Zeltiq Aesthetics

ZELTIQ Aesthetics, Inc is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. Its product, the CoolSculpting System, is designed to reduce stubborn fat bulges. It sell the CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists, and obstetrics and gynecology physicians.

5 Day Chart for NASDAQ:ZLTQ

Want to see what other hedge funds are holding ZLTQ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zeltiq Aesthetics Inc. (NASDAQ:ZLTQ).

Receive News & Ratings for Zeltiq Aesthetics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zeltiq Aesthetics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.